Top Wall Street Stories: Opko Health (NYSE:OPK), Trevena (NASDAQ:TRVN), MV Oil Trust (NYSE:MVO), Pandora Media Inc (NYSE:P), BioCryst Pharmaceuticals (NASDAQ:BCRX)

On Thursday shares of Opko Health, Inc. (NYSE:OPK) closed at $16.68. Company’s sales growth for last 5 years was 83.30% and EPS growth for next 5 years is recorded as 7.50%. Opko Health, Inc. (NYSE:OPK) on May 11, 2015, declared operating and financial results for its first quarter ended March 31, 2015. Consolidated revenues increased to $30.1 million during the three months ended March 31, 2015 from $22.3 million in the comparable period of 2014.

Trevena, Inc. (NASDAQ:TRVN) in last trading activity moved up 2.52% to close at $6.92. Company weekly performance is 10.90% while its quarterly performance stands at 31.31%. Trevena, Inc. (NASDAQ:TRVN) is -15.20% away from its 52 week high. Trevena, Inc. (NASDAQ:TRVN) announced that data highlighting its preclinical TRV250 program will be presented in an oral presentation at the International Headache Congress being held in Valencia, Spain, May 14-17, 2015.

On last trading day MV Oil Trust (NYSE:MVO) decreased -2.25% to close at $11.73. Its volatility for the week is 3.55% while volatility for the month is 3.47%. MVO’s sales growth for past 5 years was 16.00% and its EPS growth for past 5 years was 16.90%. MV Oil Trust (NYSE:MVO) monthly performance is -8.86%. Analysts at Zacks
upgraded shares of MV Oil Trust (NYSE:MVO) from an “underperform” rating to a “neutral” rating

On last trading day Pandora Media Inc (NYSE:P) moved down -0.42% to close at $18.81. Its volatility for the week is 3.29% while volatility for the month is 4.09%. P’s sales growth for past 5 years was 75.60% and its EPS growth for past 5 years was 0.00%. Pandora Media Inc (NYSE:P) monthly performance is 8.41%. Pandora Media Inc (NYSE:P) said it will appeal a rate court ruling that could force the company to pay higher royalties to Broadcast Music Inc (BMI) for music licenses.

On last trading day BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) moved up 2.43% to close at $10.55. Its volatility for the week is 5.59% while volatility for the month is 4.94%. BCRX’s sales growth for past 5 years was -28.90% and its EPS growth for past 5 years was -14.20%. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) monthly performance is 7.43%. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) said Wednesday it began testing an experimental treatment on human volunteers for a rare and potentially fatal genetic disorder called hereditary angioedema.

Why Making Dramatic Moves: Trevena (NASDAQ:TRVN), The LGL Group (NYSEMKT:LGL), CHC Group (NYSE:HELI), The Dow Chemical (NYSE:DOW), Google (NASDAQ:GOOG)

On Wednesday shares of Trevena, Inc. (NASDAQ:TRVN) closed at $6.75. Trevena Inc. (NASDAQ:TRVN) on 7 May, reported a loss of $12.9 million in its first quarter. The King Of Prussia, Pennsylvania-based company said it had a loss of 33 cents per share. The biopharmaceutical company posted revenue of $625,000 in the period.

The LGL Group, Inc. (NYSEMKT:LGL) in last trading activity advanced 10.40% to close at $5.20. Company weekly performance is 9.01% while its quarterly performance stands at 33.33%. The LGL Group, Inc. (NYSEMKT:LGL) is -1.52% away from its 52 week high. The LGL Group, Inc. (NYSEMKT:LGL) announced results for the quarter ended March 31, 2015. Revenues of $5.4 million, a decrease of 11.9% compared to Q1 2014, Net loss of ($0.2) million, or ($0.07) per share, improved 78.0% vs. Q1 2014, Adjusted EBITDA of $0.1 million, or $0.03 per share, improved 114.3% vs. Q1 2014, Gross margin of 33.3%, improved 7.3 percentage points vs. Q1 2014.

On last trading day CHC Group Ltd. (NYSE:HELI) advanced 9.70% to close at $1.81. Its volatility for the week is 14.31% while volatility for the month is 10.22%. HELI’s sales growth for past 5 years was 18.30% and its EPS growth for past 5 years was 32.10%. CHC Group Ltd. (NYSE:HELI) monthly performance is 56.03%. Zacks downgraded shares of CHC Group Ltd. (NASDAQ:HELI) from a hold rating to a sell rating in a research note released on 4 May.

On last trading day The Dow Chemical Company (NYSE:DOW) decreased -0.43% to close at $50.73. Its volatility for the week is 1.21% while volatility for the month is 1.64%. DOW’s sales growth for past 5 years was 5.30% and its EPS growth for past 5 years was 68.70%. The Dow Chemical Company (NYSE:DOW) monthly performance is 3.89%. The Dow Chemical Company (NYSE:DOW) on 6 May announced that it has closed the acquisition of ExxonMobil Chemical’s 50% stake in their common Univation Technologies joint venture.

Google Inc (NASDAQ:GOOG) has 0.19% insider ownership while its institutional ownership stands at 31.90%. In last trading activity company’s stock closed at $529.62. Google has added the ability to insert a picture from your camera roll, or even take a new photo and insert it into a Google Doc or Google Slides presentation from your phone or tablet.

Watch List: Trevena (NASDAQ:TRVN), Compugen (NASDAQ:CGEN), R.R. Donnelley & Sons Company (NASDAQ:RRD), Arlington Asset Investment Corp. (NYSE:AI), Reed Elsevier (NYSE:RUK)

On Wednesday shares of Trevena, Inc. (NASDAQ:TRVN) closed at $6.75. On May 7, Trevena Inc. (NASDAQ:TRVN) announced financial results for the quarter ended March 31 2015. Net loss attributable to common stockholders for the quarter ended March 31 2015 was $12.9 million or $0.33 per share compared to $9.4 million or $0.59 per share for the quarter ended March 31 2014.

Compugen Ltd. (NASDAQ:CGEN) in last trading activity decreased -2.89% to close at $6.38. Company weekly performance is -4.78% while its quarterly performance stands at -21.53%. Compugen Ltd. (NASDAQ:CGEN) is -36.33% away from its 52 week high. On May 5, Compugen Ltd. (NASDAQ:CGEN) reported financial results for the first quarter ended March 31, 2015. Net loss for the first quarter of 2015 was $6.1 million, or $0.12 per diluted share, compared with a net loss of $1.9 million, or $0.04 per diluted share, in the comparable period of 2014.

On last trading day R.R. Donnelley & Sons Company (NASDAQ:RRD) decreased -3.33% to close at $17.71. Its volatility for the week is 3.46% while volatility for the month is 2.31%. RRD’s sales growth for past 5 years was 3.30% and its EPS growth for past 5 years was 45.60%. R.R. Donnelley & Sons Company (NASDAQ:RRD) monthly performance is -11.09%. R.R. Donnelley & Sons Company (NASDAQ:RRD) cash dividend payment of $0.26 per share is scheduled to be paid on June 01, 2015. Shareholders who purchased RRD prior to the ex-dividend date are eligible for the cash dividend payment.

Arlington Asset Investment Corp. (NYSE:AI) has 0.60% insider ownership while its institutional ownership stands at 38.60%. In last trading activity company’s stock closed at $21.16. Zacks downgraded shares of Arlington Asset Investment Corp (NYSE:AI) from a strong-buy rating to a hold rating in a report issued on Tuesday.

On last trading day Reed Elsevier PLC (NYSE:RUK) moved up 1.27% to close at $67.94. Its volatility for the week is 0.56% while volatility for the month is 0.91%. RUK’s sales growth for past 5 years was -1.00% and its EPS growth for past 5 years was 19.20%. Reed Elsevier PLC (NYSE:RUK) monthly performance is -0.24%. On May 7, it was reported that, Reed Elsevier PLC (NYSE:RUK) has issued a €600m 10 year bond through a US financing vehicle in an SEC-registered, New York-listed format, after considering issuing in either euros or dollars. The scientific, technical, medical, legal and business publisher last issued in the European bond market in July 2014, with a £300m five year deal.

Trader’s Recap: Alcatel Lucent SA (ADR) (NYSE:ALU), Trevena (NASDAQ:TRVN), Koppers Holdings Inc. (NYSE:KOP), Comcast Corporation (NASDAQ:CMCSA), Digi International Inc. (NASDAQ:DGII)

On Tuesday shares of Alcatel Lucent SA (ADR) (NYSE:ALU) closed at $4.93. Company’s sales growth for last 5 years was -2.30%. On 7 April, Alcatel Lucent SA (ADR) (NYSE:ALU) and Accenture announced four-year agreement with Telefonica to deploy Alcatel-Lucent’s motive customer experience management software

Trevena, Inc. (NASDAQ:TRVN) in last trading activity fell -1.84% to close at $6.95. Company weekly performance is 1.16% while its quarterly performance stands at 17.40%. Trevena, Inc. (NASDAQ:TRVN) is -14.83% away from its 52 week high. Trevena, Inc. (NASDAQ:TRVN) announced Maxine Gowen, Ph.D., its chief executive officer, will present a company overview at the 14th Annual Needham Healthcare Conference on Wednesday, April 15, 2015 at 10:00 a.m. EDT in New York.

On last trading day Koppers Holdings Inc. (NYSE:KOP) increased 1.64% to close at $19.87. Its volatility for the week is 2.68% while volatility for the month is 4.32%. KOP’s sales growth for past 5 years was 6.70% and its EPS growth for past 5 years was -30.10%. Koppers Holdings Inc. (NYSE:KOP) monthly performance is 2.05%. Koppers Holdings Inc. (NYSE:KOP) said that, it intends to release its first quarter 2015 financial results before the opening of the markets on Friday, May 8, 2015, and discuss its results on a conference call later that day at 11:00 a.m. EDT. Presentation materials will be available online at least 15 minutes before the call.

On last trading day Comcast Corporation (NASDAQ:CMCSA) moved up 0.33% to close at $58.97. Its volatility for the week is 1.40% while volatility for the month is 1.64%. CMCSA’s sales growth for past 5 years was 14.00% and its EPS growth for past 5 years was 20.50%. Comcast Corporation (NASDAQ:CMCSA) monthly performance is 0.31%. On 9 April, Comcast Corporation (NASDAQ:CMCSA) said that, its team is in South Lake Union restored Internet, phone and TV to 33,000 people who couldn’t call 911 from their landline phones.

On last trading day Digi International Inc. (NASDAQ:DGII) fell -0.41% to close at $9.71. Its volatility for the week is 2.17% while volatility for the month is 2.92%. DGII’s sales growth for past 5 years was 3.00% and its EPS growth for past 5 years was -15.20%. Digi International Inc. (NASDAQ:DGII) monthly performance is -5.18%. Digi International Inc. (NASDAQ:DGII)‘s stock had its “buy” rating reaffirmed by equities research analysts at Canaccord Genuity in a research note issued to investors on Tuesday. They currently have a $12.00 target price on the stock. Canaccord Genuity’s target price would indicate a potential upside of 15.50% from the stock’s previous close.

Investors Alert: Intel Corporation (NASDAQ:INTC), Trevena (NASDAQ:TRVN), PTC Inc. (NASDAQ:PTC), WPP plc (NASDAQ:WPPGY)

Intel Corporation (NASDAQ:INTC) in last trading activity moved down -0.60% to close at $31.27. Company weekly performance is 1.56% while its quarterly performance stands at -15.30%. Intel Corporation (NASDAQ:INTC) is -16.90% away from its 52 week high. Intel Corporation (NASDAQ:INTC) has quietly launched its first 14nm Braswell cores this week. These new 14nm chips are the successor to Intel’s 22nm Bay Trail-D (meaning the Celeron / Pentium flavor of Bay Trail) and will target ultra-mobile systems and low-end desktop PCs. Just as Broadwell is a die-shrink of Haswell, Braswell is Bay Trail’s die shrink — which means the 14nm “Airmont” CPU core inside the SoC isn’t expected to offer dramatically new features or other capabilities compared with its predecessor. Increased efficiency, lower TDPs, and better thermals are the order of the day. Intel’s Cherry Trail, which will debut later this year, will offer the same silicon in a tablet power envelope.

On last trading day Trevena, Inc. (NASDAQ:TRVN) moved down -1.81% to close at $6.52. Its volatility for the week is 11.42% while volatility for the month is 8.25%. Trevena, Inc. (NASDAQ:TRVN) monthly performance is 22.79%. Trevena, Inc. (NASDAQ: TRVN announced David Soergel, M.D., its chief medical officer, presented a company overview at the BioCentury 22nd Annual Future Leaders in the Biotech Industry conference on Friday March 20, 2015 at 3:00 p.m. EDT in New York.

PTC Inc. (NASDAQ:PTC) has 1.40% insider ownership while its institutional ownership stands at 96.40%. In last trading activity company’s stock closed at $36.17. On March 26, PTC (NASDAQ:PTC) announced that Robert Schechter has assumed the role of chairman of the company’s Board of Directors. Schechter, a PTC director since 2009, is former CEO of NMS Communications Corporation, a provider of hardware and software solutions for the communications industry. He has considerable experience in the technology industry, currently serving on the boards of Tremor Video Inc. and EXA Corporation and previously serving on the boards of Unica Corporation and Soapstone Networks. Schechter succeeds Donald Grierson, who will continue to serve on PTC’s board.

On last trading day WPP plc (NASDAQ:WPPGY) moved down -1.74% to close at $113.77. Its volatility for the week is 1.22% while volatility for the month is 1.12%. WPPGY’s sales growth for past 5 years was 8.10% and its EPS growth for past 5 years was 13.10%. WPP plc (NASDAQ:WPPGY) monthly performance is -4.18%. Macquarie restated their outperform rating on shares of Wpp Plc (NASDAQ:WPPGY) in a report issued on Tuesday. They currently have a GBX 1,650 ($24.54) target price on the stock.

Trader’s Alert: Trevena (NASDAQ:TRVN), TherapeuticsMD (NYSEMKT:TXMD), Landstar System Inc. (NASDAQ:LSTR), Allison Transmission Holdings (NYSE:ALSN)

Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company, announced that it will host a conference call on Wednesday, March 18, 2015 at 8:30 a.m. Eastern Time to discuss corporate updates and financial results for the year ended December 31, 2014. On Thursday shares of Trevena, Inc. (NASDAQ:TRVN) closed at $6.25.

On March 10, TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women’s healthcare company, announced its fourth quarter and full-year financial results for the period ending Dec. 31, 2014. Net revenue increased to approximately $15.0 million in 2014 compared with approximately $8.8 million in the prior year, reflecting a 71 percent increase in product sales. Net loss was approximately $54.2 million in 2014 compared with approximately $28.4 million in the prior year, reflecting the company’s increased investment in clinical trials for two phase 3 pipeline products. TherapeuticsMD, Inc. (NYSEMKT:TXMD) in last trading activity moved up 7.62% to close at $5.65. Company weekly performance is 8.45% while its quarterly performance stands at 45.24%. TherapeuticsMD, Inc. (NYSEMKT:TXMD) is -29.11% away from its 52 week high.

Shares of Landstar System (NASDAQ:LSTR) have received an average recommendation of “Hold” from the thirteen brokerages that are covering the stock, Analyst RN reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company. Landstar System Inc. (NASDAQ:LSTR) has 0.50% insider ownership. In last trading activity company’s stock closed at $68.58.

On March 4, Allison Transmission Holdings Inc. (NYSE:ALSN), announced that David S. Graziosi, Executive Vice President and Chief Financial Officer, and G. Frederick Bohley III, Executive Director of Finance, Business Planning and Investor Relations will present at the Bank of America Merrill Lynch’s Global Industrials & EU Autos Conference – London on Tuesday, March 17 at 9:40 a.m. GMT (5:40 a.m. EDT). On last trading day Allison Transmission Holdings, Inc. (NYSE:ALSN) moved up 1.28% to close at $31.61. Its volatility for the week is 1.17% while volatility for the month is 1.42%. ALSN’s sales growth for past 5 years was 3.80% and its EPS growth for past 5 years was 22.00%. Allison Transmission Holdings, Inc. (NYSE:ALSN) monthly performance is 1.31%.

Stock Alert: Molycorp (NYSE:MCP), Pfenex Inc. (NYSEMKT:PFNX), Starwood Hotels & Resorts Worldwide Inc. (NYSE:HOT), Mesa Laboratories Inc. (NASDAQ:MLAB), Trevena (NASDAQ:TRVN)

On 2 February, Molycorp, Inc. (NYSE:MCP) reported that rare earth production in the fourth quarter of 2014 at its Mountain Pass, California facility increased year-on-year and nearly doubled that of the preceding quarter. Mountain Pass completed Q4 of 2014 with 1,328 metric tons (mt) of rare earth oxide (REO) equivalent production. That compares to 1,034 mt in Q4 of 2013 and 691 mt in Q3 of 2014. On Thursday shares of Molycorp, Inc. (NYSE:MCP) closed at $0.93. Company’s sales growth for last 5 years was 205.00% and EPS growth for next 5 years is recorded as 15.00%.

On 10 February, Pfenex Inc. (NYSEMKT:PFNX) and Hospira, Inc., (NYSE: HSP) announced that the companies have entered into an agreement to exclusively develop and commercialize for worldwide sales PF582, Pfenex’s biosimilar candidate to Genentech’sLUCENTIS® (ranibizumab injection). Pfenex Inc. (NYSEMKT:PFNX) in last trading activity advanced 24.72% to close at $12.16. Company weekly performance is 81.49% while its quarterly performance stands at 45.45%. Pfenex Inc. (NYSEMKT:PFNX) is 23.08% away from its 52 week high.

On 10 February, Starwood Hotels & Resorts Worldwide Inc. (NYSE:HOT) reported an 83 percent jump in quarterly profit and said it would spin off its vacation ownership business. The company’s net income rose to $234 million, or $1.34 per share, in the fourth quarter ended Dec. 31, from $128 million, or 68 cents per share, a year earlier. On last trading day Starwood Hotels & Resorts Worldwide Inc. (NYSE:HOT) advanced 2.12% to close at $77.88. Its volatility for the week is 2.78% while volatility for the month is 2.34%. HOT’s sales growth for past 5 years was 1.20% and its EPS growth for past 5 years was 16.80%. Starwood Hotels & Resorts Worldwide Inc. (NYSE:HOT) monthly performance is 5.20%.

On 2 February, Mesa Laboratories Inc. (NASDAQ:MLAB) reported record revenues and net income for the third quarter ended December 31, 2014. Revenues for the third quarter increased 36 percent to $17,830,000 as compared to $13,116,000 for the same quarter last year. Net income for the third quarter increased 38 percent to $2,403,000 or $0.66 per diluted share of common stock as compared to $1,746,000 or $0.48 per diluted share of common stock for the same quarter last year. Mesa Laboratories Inc. (NASDAQ:MLAB) has 9.10% insider ownership while its institutional ownership stands at 47.90%. In last trading activity company’s stock closed at $75.16.

On 9 February, Trevena, Inc. (NASDAQ:TRVN) announced positive data from a Phase 1 multiple ascending dose study of TRV734, a novel drug candidate in development as an orally administered treatment for moderate-to-severe acute and chronic pain. TRV734 showed pharmacokinetics, safety, tolerability, and CNS activity consistent with a previous Phase 1 study, and showed effectiveness similar to immediate-release oxycodone in an experimental pain model. On last trading day Trevena, Inc. (NASDAQ:TRVN) decreased -0.38% to close at $5.27. Its volatility for the week is 5.93% while volatility for the month is 5.96%. Trevena, Inc. (NASDAQ:TRVN) monthly performance is -12.02%.

Biotechnology Top Gainers: Calithera Biosciences (NASDAQ:CALA), EPIRUS Biopharmaceuticals (NASDAQ:EPRS), Coherus Biosciences (NASDAQ:CHRS), Trevena (NASDAQ:TRVN), Cellular Biomedicine Group (NASDAQ:CBMG)

On 30 January, Calithera Biosciences, Inc. (NASDAQ:CALA), announced the appointment of Dr. Keith Orford, M.D. Ph.D., as Vice President of Clinical Development. He joins the company following a distinguished career in oncology pharmaceuticals development, including senior clinical roles with GlaxoSmithKline (GSK) and Merck. At Calithera, Dr. Orford will be responsible for clinical development of CB-839, its lead oral product candidate in tumor metabolism, as well as subsequent clinical development programs. On Monday shares of Calithera Biosciences, Inc. (NASDAQ:CALA) closed at $18.18. Company’s EPS growth for next 5 years is recorded as 75.00%.

EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS), announced that the Company is scheduled to present a corporate overview at the Leerink Global Healthcare Conference in New York City on Thursday, February 12, 2015 at 11:35 a.m. Eastern Time. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) in last trading activity increased 15.26% to close at $5.59. Company weekly performance is 11.80% while its quarterly performance stands at 16.46%. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) is -67.87% away from its 52 week high.

Coherus BioSciences, Inc. (NASDAQ:CHRS), announced that it will participate in a fireside chat at the 2015 Leerink Global Healthcare Conference on Wednesday, February 11 at 1:50 pm ET in New York City. On last trading day Coherus Biosciences, Inc. (NASDAQ:CHRS) increased 12.91% to close at $32.36. Its volatility for the week is 14.21% while volatility for the month is 10.09%. CHRS’s EPS growth for past 5 years was -44.33%. Coherus Biosciences, Inc. (NASDAQ:CHRS) monthly performance is 51.78%.

Trevena, Inc. (NASDAQ: TRVN), announced positive data from a Phase 1 multiple ascending dose study of TRV734, a novel drug candidate in development as an orally administered treatment for moderate-to-severe acute and chronic pain. Trevena, Inc. (NASDAQ:TRVN) has 1.50% insider ownership while its institutional ownership stands at 76.40%. In last trading activity company’s stock closed at $5.35.

Cellular Biomedicine Group Inc. (NASDAQ:CBMG) announced its acquisition of Chinese PLA General Hospital’s (“PLAGH”, Beijing, also known as “301 Hospital”) Chimeric Antigen Receptor T cell (CAR-T) therapy, its recombinant expression vector CD19, CD20, CD30 and Human Epidermal Growth Factor Receptor’s (EGFR or HER1) Immuno-Oncology patents (all pending), and Phase I/II clinical data of the aforementioned therapies and manufacturing knowledge. On last trading day Cellular Biomedicine Group Inc. (NASDAQ:CBMG) increased 10.85% to close at $23.40. Its volatility for the week is 10.87% while volatility for the month is 8.60%. CBMG’s EPS growth for past 5 years was -19.20%. Cellular Biomedicine Group Inc. (NASDAQ:CBMG) monthly performance is 55.90%.

Stocks Swings: Zogenix (NASDAQ:ZGNX), Swift Energy Co. (NYSE:SFY), Western Digital Corporation (NASDAQ:WDC), BankFinancial Corp. (NASDAQ:BFIN), Trevena (NASDAQ:TRVN)

Zogenix, Inc. (NASDAQ:ZGNX) has received U.S. approval for a new formulation of its much-debated painkiller Zohydro that is intended to be harder to abuse, though the company is still working on studies needed to promote that claim. On Tuesday shares of Zogenix, Inc. (NASDAQ:ZGNX) closed at $1.28. Company’s EPS growth for next 5 years is recorded as 25.00%.

On Jan 26, Swift Energy Company (NYSE:SFY) said it will report its fourth quarter and year-end 2014 financial and operational results on Thursday, February 26, 2015 by issuing a news release before the market opens and conducting a conference call to discuss such results on that date at 9:00 a.m. CST. Swift Energy Co. (NYSE:SFY) in last trading activity advanced 9.91% to close at $2.44. Company weekly performance is 6.55% while its quarterly performance stands at -64.38%. Swift Energy Co. (NYSE:SFY) is -81.40% away from its 52 week high.

Western Digital Corp. (NASDAQ:WDC) announced that the board of directors authorized an additional $2.0 billion for share repurchases by the company. As of February 2, 2015, the company had approximately $384 million remaining under prior share repurchase authorizations. The additional repurchase authorization is effective immediately. On Tuesday shares of Western Digital Corporation (NASDAQ:WDC) closed at $100.68. Company’s sales growth for last 5 years was 15.20% and EPS growth for next 5 years is recorded as 8.35%.

BankFinancial Corporation (NASDAQ:BFIN) announced that its Board of Directors declared a cash dividend of $0.04 per common share. The dividend will be payable on March 6, 2015 to stockholders of record on February 18, 2015. BankFinancial Corp. (NASDAQ:BFIN) has 20.67% insider ownership while its institutional ownership stands at 63.00%. In last trading activity company’s stock closed at $11.83.

Trevena, Inc. (NASDAQ:TRVN) announced that Maxine Gowen, Ph.D., its president and chief executive officer, will present a company overview at the 17th Annual BIO CEO & Investor Conference on Tuesday February 10, 2015 at 8:00 a.m. EST in New York City. On last trading day Trevena, Inc. (NASDAQ:TRVN) decreased -2.28% to close at $5.15. Its volatility for the week is 5.66% while volatility for the month is 6.12%. Trevena, Inc. (NASDAQ:TRVN) monthly performance is -8.85%.

Stocks to Watch: UnitedHealth Group Incorporated (NYSE:UNH), NanoViricides (NYSEMKT:NNVC), Oshkosh Corporation (NYSE:OSK), AT&T (NYSE:T), Trevena (NASDAQ:TRVN)

UnitedHealth Group Inc. (NYSE:UNH) will donate 250 computers to local organizations to increase computer and Internet access in underserved communities. On Thursday shares of UnitedHealth Group Incorporated (NYSE:UNH) closed at $113.85. Company’s sales growth for last 5 years was 8.60% and EPS growth for next 5 years is recorded as 9.29%.

NanoViricides, Inc. (NYSEMKT:NNVC) reported that it has shipped several anti-Ebola nanoviricide® drug candidates to a hi-security bio-containment facility in the US that is capable of performing evaluation of these drug candidates in the required biological safety level 4 (BSL-4) environment. NanoViricides, Inc. (NYSEMKT:NNVC) in last trading activity advanced 11.81% to close at $2.84. Company weekly performance is 2.90% while its quarterly performance stands at -22.40%. NanoViricides, Inc. (NYSEMKT:NNVC) is -44.64% away from its 52 week high.

Oshkosh Corporation (NYSE:OSK) will hold its 2015 annual shareholders’ meeting at 8:00 a.m. CST on Tuesday, February 3, 2015, at the Oshkosh Convention Center in Oshkosh, Wis. On last trading day Oshkosh Corporation (NYSE:OSK) advanced 2.96% to close at $41.40. Its volatility for the week is 2.88% while volatility for the month is 2.63%. OSK’s sales growth for past 5 years was 5.30% and its EPS growth for past 5 years was 17.50%. Oshkosh Corporation (NYSE:OSK) monthly performance is -12.33%.

AT&T Inc. (NYSE:T) has put the name of its DirecTV unit under review, according to company chief executive Randall Stephenson . On Thursday shares of AT&T, Inc. (NYSE:T) closed at $33.53. Company’s sales growth for last 5 years was 0.80% and EPS growth for next 5 years is recorded as 4.60%.

Trevena Inc (NASDAQ:TRVN) encountered a rise of 270.9% or 60,579 shares in the short positions. The number escalated from 22,359 on December 15,2014 to 82,938 on December 31,2014. The final interest is 0.5% of the floated stock. The days to cover figure of 1 can be arrived using the average daily exchange of 144,693 shares. On last trading day Trevena, Inc. (NASDAQ:TRVN) advanced 2.47% to close at $5.80. Its volatility for the week is 5.37% while volatility for the month is 7.06%. Trevena, Inc. (NASDAQ:TRVN) monthly performance is 9.43%.